Dec 21, 2015 8:30am EST OPKO’s GeneDx Study of More Than 10,000 Individuals Tested with Multigene NGS Hereditary Cancer Panel Reveals New Risks
Dec 09, 2015 8:30am EST OPKO’s GeneDx Study Demonstrates Whole Exome Sequencing Usefulness In Diagnosing Rare Disorders
Nov 17, 2015 12:31pm EST OPKO Health to Present at the Jefferies Autumn 2015 Global Healthcare Conference
Nov 16, 2015 11:26am EST OPKO Licensee TESARO Announces the Launch of VARUBI(TM) (Rolapitant) in the United States
Nov 05, 2015 1:58pm EST OPKO to Announce Third Quarter Operating and Financial Results on November 9, 2015
Nov 05, 2015 8:30am EST Additional Phase 3 Data Supporting OPKO’s Rayaldee as a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at Kidney Week 2015